15
2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11882 |
Pulrodemstat benzenesulfonate
LSD1-IN-7 benzenesulfonate,CC-90011 benzenesulfonate |
Histone Demethylase | Chromatin/Epigenetic |
Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) 是一种有效的口服活性赖氨酸特异性去甲基化酶 1 (LSD1) 抑制剂,IC50为 0.25 nM,具有抗癌活性。它诱导急性髓细胞性白血病和小细胞肺癌细胞分化,对 LSD2、MOA-A 和 MAO-B 的酶抑制作用较小。 | |||
T1602 |
Valproic acid sodium salt
丙戊酸钠,Sodium Valproate |
Mitophagy; Gamma-secretase; HIV Protease; GABA Receptor; HDAC; Autophagy | Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience; Proteases/Proteasome; Stem Cells |
Valproic acid sodium salt (Sodium Valproate) 是一种HDAC 抑制剂,可抑制HDAC1的活性,诱导HDAC2的降解。它激活Notch1信号并抑制小细胞肺癌细胞的增殖。它可研究癫痫、偏头痛和双相情感障碍等。 | |||
T6474 |
Divalproex Sodium
Valproate semisodium,Epival,双丙戊酸钠 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Divalproex Sodium (Valproate semisodium) 结合并抑制 γ-氨基丁酸 (GABA) 转氨酶,其抗惊厥活性可通过增加 GABA 脑浓度和抑制分解 GABA 或阻止 GABA 再摄取到神经胶质和神经末梢的酶来发挥。它也是一种 HDAC 抑制剂。由丙戊酸钠和丙戊酸组成,具有抗惊厥和抗癫痫活性。 Divalproex 还可以通过抑制电压敏感的钠通道来抑制重复的神经元放电。 | |||
T20168 |
Aurothiomalate sodium
金硫丁二钠,Myocrisin,Myocrisine,Miochrysin,Sodium aurothiomalate,Myochrysine,gold sodium thiomalate |
Others; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; Others |
Aurothiomalate sodium (Miochrysin) 是一种选择性的致癌 PKCι信号传导抑制剂,可抑制肿瘤细胞增殖。它是一种硫氧还蛋白还原酶 (TrxR) 抑制剂,也是一种抗风湿剂。 | |||
T14685 |
BMS-986158
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BMS-986158 是一种BET 抑制剂,在 MDA-MB231 三阴性乳腺癌细胞和 NCI-H211 小细胞肺癌细胞中,对 BET 的IC50分别为 5 和 6.6 nM。 | |||
T67934 |
MRT-2359
|
Others | Others |
MRT-2359 是一种有效的且可口服的 GSPT1 降解剂,具有抗肿瘤活性。MRT-2359 对耐药非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 细胞的生长具有抑制作用。MRT-2359 在 MYC 驱动的细胞系中表现出优先活性。 | |||
T76698 |
Rovalpituzumab
|
Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
Rovalpituzumab 是一种靶向 delta 样蛋白 3 (DLL3) 的人源化单克隆抗体。Rovalpituzumab 可用于合成抗体-活性分子偶联物 (ADC)。Rovalpituzumab 具有抗癌活性,可用于治疗小细胞肺癌 (SCLC)。 | |||
T70008 |
Bomedemstat ditosylate
MK-3543 ditosylate,IMG-7289 ditosylate |
Apoptosis; Histone Demethylase | Apoptosis; Chromatin/Epigenetic |
Bomedemstat ditosylate (IMG-7289 ditosylate) 是一种具有口服活性的 lysine-specific demethylase 1 (LSD1) 抑制剂,具有抗肿瘤活性,增强 SCLC 同基因模型中对 PD-1 抑制的反应,抑制癌细胞增殖,诱导细胞凋亡。Bomedemstat ditosylate 可用于研究骨髓增生性肿瘤和骨髓纤维化。 | |||
T3062 |
WIKI4
|
PARP; Wnt/beta-catenin | Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Stem Cells |
WIKI4 是tankyrase 有效抑制剂,其对TNKS2的IC50值为 26 nM。它有效抑制Wnt/β-catenin 信号传导,其EC50值为 75 nM。它通过抑制TNKS2的酶活性来介导其对Wnt/β-catenin 信号传导的影响。它对 SCLC 细胞具有细胞毒性,其IC50值为 0.02 μM。 | |||
T71620 |
iBAP-II
|
Others | Others |
iBAP-II represses neuroendocrine lineage-specific ASCL1/MYCL/E2F signaling in SCLC cell lines, and dramatically inhibits SCLC cell viability and tumor growth in vivo. | |||
T4134L |
OTS514
OTS514 HCl,OTS514 Hydrochloride,OTS-514,OTS 514 |
Apoptosis; TOPK | Apoptosis; MAPK |
OTS514 (OTS514 Hydrochloride) 是一种高效的 TOPK 抑制剂,IC50为 2.6 nM。它强效抑制 TOPK 阳性的肿瘤细胞生长,还可诱导细胞周期停滞和凋亡。 | |||
T76986 |
Tarlatamab
|
||
Tarlatamab (AMG-757) 是一种双特异性 T 细胞接合剂 (BiTE) 抗体,靶向 delta 样配体 3 (DLL3)。DLL3 是在小细胞肺癌 (SCLC) 肿瘤中选择性表达的靶标,但在正常组织中表达很少。Tarlatamab 对人和非人灵长类动物 (NHP) 的 DLL3 的KD 分别为 0.64 nM 和 0.50 nM,对CD3的KD 分别为 14.9 nM 和 12 nM。Tarlatamab 是针对 DLL3 的一流 HLE BiTE 免疫肿瘤疗法,具有用于 SCLC 研究的潜力。 | |||
T76899 |
Adebrelimab
|
||
Adebrelimab (SHR-1316) 是一种人源化IgG4单克隆抗体,针对PD-L1(PD-1/PD-L1)具有良好的抗肿瘤活性。该药物在包括广泛期小细胞肺癌(SCLC)在内的多种实体瘤中表现出效果。 | |||
T28999 |
TPC-144
TPC144,TPC 144 |
Others | Others |
TPC-144 is a potent and selective LSD1 inhibitor with a reversible inhibition mechanism. TPC-144 has antitumor activity in several human AML and SCLC cell lines and xenograft models. | |||
T39258 |
Pulrodemstat
LSD1-IN-7,CC-90011 |
Others | Others |
Pulrodemstat (CC-90011) is a highly potent and selective inhibitor of lysine specific demethylase-1 (LSD1). It exhibits a reversible mode of action and can be administered orally. With an impressive IC50 of 0.25 nM, Pulrodemstat effectively suppresses the enzymatic activity of LSD1. Notably, it demonstrates minimal inhibition against LSD2, MOA-A, and MAO-B enzymes. Moreover, Pulrodemstat possesses remarkable anticancer properties, promoting differentiation in acute myeloid leukemia (AML) and sma... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7064 |
Valproic Acid
Sodium valproate,2-Propylpentanoic Acid,丙戊酸,VPA,Depakine,2-Propylvaleric Acid |
Mitophagy; Gamma-secretase; HIV Protease; GABA Receptor; Sodium Channel; HDAC; Autophagy | Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience; Proteases/Proteasome; Stem Cells |
Valproic Acid (2-Propylpentanoic Acid) 是一种 HDAC 抑制剂,可抑制 HDAC1 活性,诱导 HDAC2 降解,具有口服活性。Valproic Acid 可以用于癫痫和躁郁症的研究。 | |||
T5S0506 |
Rotundic acid
Rutundic acid,铁冬青酸 |
Apoptosis; Others; p38 MAPK; Akt; mTOR | Apoptosis; Cytoskeletal Signaling; MAPK; Others; PI3K/Akt/mTOR signaling |
Rotundic acid (Rutundic acid) 是一种从圆形肠球菌中获得的三萜类天然产物,具有抗炎和保护心脏的能力。它可通过 AKT/mTOR 和 MAPK 途径在肝细胞癌中诱导 DNA 损伤和细胞凋亡。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04801 |
Fibromodulin Protein, Human, Recombinant (hFc)
FM,fibromodulin,SLRR2E |
Human | HEK293 Cells |
Fibromodulin (FMOD), an ECM small leucine-rich proteoglycan (SLRP), was reported to promote angiogenesis not only during wound healing, but also in optical and cutaneous angiogenesis-dependent diseases. The autocrine FMOD of cancer cells may promote tumor angiogenesis of SCLC by upregulating the expression of angiogenic factors that act in concert to facilitate the angiogenic phenotype of endothelial cells as a proangiogenic factor. Therefore, silencing FMOD may be a potentially clinical therap... |